睿科企业管理(上海)有限公司 RUIKE
{{company.company_channel.channel_name}}
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Gracell Bio Announces FasT CAR-T, a Breakthrough Technology for Hematological Malignancies 2019-04-23 17:08
Gracell Biotechnologies Completes $85 Million Series B for Immune Cell Gene Therapies 2019-02-26 08:07
1